Clinical Trial Update: High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-protein and exercise therapy with nocturnal enteral feeding for juvenile-onset Pompe disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Snippet

Sponsor: Columbia University | Conditions: Glycogen Storage Disease Type II | Phase 2 | Status: WITHDRAWN